Skip to content
10-Q

Quarterly Report

HARVARD BIOSCIENCE INC HBIO

0001171843-26-003311

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 4.51M sh
Shares Diluted Q1 2026 · Mar 31, 2026 4.47M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 4.41M sh
Capex Q1 2026 · Mar 31, 2026 $426K
Capex Q1 2026 · Mar 31, 2025 $513K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$662K
Operating Cash Flow Q1 2026 · Mar 31, 2025 $2.99M
Long Term Debt Q1 2026 · Mar 31, 2026 $36.21M
Long Term Debt Q1 2026 · Dec 31, 2025 $35.87M
Short Term Debt Q1 2026 · Mar 31, 2026 $0
Short Term Debt Q1 2026 · Dec 31, 2025 $0
Cash And Equivalents Q1 2026 · Mar 31, 2026 $7.1M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $8.61M
Stockholders Equity Q1 2026 · Mar 31, 2026 $10.05M
Stockholders Equity Q1 2026 · Dec 31, 2025 $13.73M
Stockholders Equity Q1 2026 · Mar 31, 2025 $14.84M
Stockholders Equity Q1 2026 · Dec 31, 2024 $63.34M
Current Liabilities Q1 2026 · Mar 31, 2026 $23.86M
Current Liabilities Q1 2026 · Dec 31, 2025 $21.96M
Total Liabilities Q1 2026 · Mar 31, 2026 $67.89M
Total Liabilities Q1 2026 · Dec 31, 2025 $66.34M
Current Assets Q1 2026 · Mar 31, 2026 $47.48M
Current Assets Q1 2026 · Dec 31, 2025 $48.23M
Total Assets Q1 2026 · Mar 31, 2026 $77.94M
Total Assets Q1 2026 · Dec 31, 2025 $80.07M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.77
Eps Diluted restated Q1 2026 · Mar 31, 2025 −$11.42
Eps Basic Q1 2026 · Mar 31, 2026 −$0.77
Eps Basic restated Q1 2026 · Mar 31, 2025 −$11.42
Sga Expense Q1 2026 · Mar 31, 2026 $4.7M
Sga Expense Q1 2026 · Mar 31, 2025 $5.19M
Rd Expense Q1 2026 · Mar 31, 2026 $2.33M
Rd Expense Q1 2026 · Mar 31, 2025 $2.32M
Net Income Q1 2026 · Mar 31, 2026 −$3.42M
Net Income Q1 2026 · Mar 31, 2025 −$50.34M
Operating Income Q1 2026 · Mar 31, 2026 −$1.17M
Operating Income Q1 2026 · Mar 31, 2025 −$49.67M
Gross Profit Q1 2026 · Mar 31, 2026 $12.24M
Gross Profit Q1 2026 · Mar 31, 2025 $12.18M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $8.51M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $9.59M
Revenue Q1 2026 · Mar 31, 2026 $20.76M
Revenue Q1 2026 · Mar 31, 2025 $21.77M